149 related articles for article (PubMed ID: 33164288)
1. Evaluation of time to clearance of high-dose methotrexate using the ARK immunoassay in pediatric hematology/oncology patients: A single-center experience.
Kowalski KE; Higgins TA
Pediatr Blood Cancer; 2021 Mar; 68(3):e28788. PubMed ID: 33164288
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a Methotrexate Chemiluminescent Microparticle Immunoassay: Comparison to Fluorescence Polarization Immunoassay and Liquid Chromatography-Tandem Mass Spectrometry.
Bouquié R; Grégoire M; Hernando H; Azoulay C; Dailly E; Monteil-Ganière C; Pineau A; Deslandes G; Jolliet P
Am J Clin Pathol; 2016 Jul; 146(1):119-24. PubMed ID: 27357291
[TBL] [Abstract][Full Text] [Related]
3. Head to head evaluation of the analytical performance of two commercial methotrexate immunoassays and comparison with liquid chromatography-mass spectrometry and the former fluorescence polarization immunoassay.
Günther V; Mueller D; von Eckardstein A; Saleh L
Clin Chem Lab Med; 2016 May; 54(5):823-31. PubMed ID: 26457783
[TBL] [Abstract][Full Text] [Related]
4. Unexpected overestimation of methotrexate plasma concentrations: analysis of a single center pediatric population.
Guerriero E; Simon N; Nelken B; Baldeyrou B; Djobo B; Vasseur M; Allorge D; Décaudin B; Odou P
Ther Drug Monit; 2014 Aug; 36(4):499-504. PubMed ID: 25014075
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic drug monitoring of methotrexate on the pediatric oncology ward: can blood sampling from central venous accesses substitute for capillary finger punctures?
Ritzmo C; Albertioni F; Cosic K; Söderhäll S; Eksborg S
Ther Drug Monit; 2007 Aug; 29(4):447-51. PubMed ID: 17667799
[TBL] [Abstract][Full Text] [Related]
6. The influence of 7-OH methotrexate metabolite on clinical relevance of methotrexate determination.
Klapkova E; Kukacka J; Kotaska K; Suchanska I; Urinovska R; Prusa R
Clin Lab; 2011; 57(7-8):599-606. PubMed ID: 21888024
[TBL] [Abstract][Full Text] [Related]
7. Comparison of a new serum topiramate immunoassay to fluorescence polarization immunoassay.
Snozek CL; Rollins LA; Peterson PW; Langman LJ
Ther Drug Monit; 2010 Feb; 32(1):107-11. PubMed ID: 20010458
[TBL] [Abstract][Full Text] [Related]
8. Severe acute renal failure following high-dose methotrexate therapy in adults with haematological malignancies: a significant number result from unrecognized co-administration of several drugs.
de Miguel D; García-Suárez J; Martín Y; Gil-Fernández JJ; Burgaleta C
Nephrol Dial Transplant; 2008 Dec; 23(12):3762-6. PubMed ID: 18779628
[No Abstract] [Full Text] [Related]
9. Effect of Levetiracetam on Time to High-Dose Methotrexate Clearance in Patients With Hematologic Malignancies.
Lou U; Kwok J; Nguyen TA; Zhou A; Luk SO
J Clin Pharmacol; 2020 Mar; 60(3):324-330. PubMed ID: 31729053
[TBL] [Abstract][Full Text] [Related]
10. [Determining the methotrexate concentration in serum with the fluorescence polarization immunoassay (FPIA)--a comparison with the enzyme immunoassay (EMIT)].
Liappis N
Klin Padiatr; 1986; 198(1):33-6. PubMed ID: 3515034
[TBL] [Abstract][Full Text] [Related]
11. Comparison of four immunoassays to an HPLC method for the therapeutic drug monitoring of methotrexate: Influence of the hydroxylated metabolite levels and impact on clinical threshold.
Descoeur J; Dupuy AM; Bargnoux AS; Cristol JP; Mathieu O
J Oncol Pharm Pract; 2022 Jan; 28(1):55-63. PubMed ID: 33427019
[TBL] [Abstract][Full Text] [Related]
12. Comparable efficacy with varying dosages of glucarpidase in pediatric oncology patients.
Scott JR; Zhou Y; Cheng C; Ward DA; Swanson HD; Molinelli AR; Stewart CF; Navid F; Jeha S; Relling MV; Crews KR
Pediatr Blood Cancer; 2015 Sep; 62(9):1518-22. PubMed ID: 25631103
[TBL] [Abstract][Full Text] [Related]
13. Multicenter method evaluation of the ARK™ Methotrexate Immunoassay.
Godefroid MJ; von Meyer A; Parsch H; Streichert T; Verstraete AG; Stove V
Clin Chem Lab Med; 2014 Feb; 52(2):e13-6. PubMed ID: 24114913
[No Abstract] [Full Text] [Related]
14. Effective removal of methotrexate by high-flux hemodialysis.
Saland JM; Leavey PJ; Bash RO; Hansch E; Arbus GS; Quigley R
Pediatr Nephrol; 2002 Oct; 17(10):825-9. PubMed ID: 12376811
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of high-dose methotrexate for osteosarcoma in adolescents compared with young adults.
Wippel B; Gundle KR; Dang T; Paxton J; Bubalo J; Stork L; Fu R; Ryan CW; Davis LE
Cancer Med; 2019 Jan; 8(1):111-116. PubMed ID: 30580500
[TBL] [Abstract][Full Text] [Related]
16. [Blood concentration monitoring during high-dose methotrexate treatment].
Jiao L; Zhou DB; Wang SJ; Zhang W; Duan MH; Li J; Han B; Xu Y; Zhao YQ; Shen T; Wang Q; Ye M
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Oct; 31(5):564-6. PubMed ID: 19968071
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Novel Methotrexate Architect Chemiluminescent Immunoassay: Clinical Impact on Pharmacokinetic Monitoring.
Aumente MD; López-Santamaría J; Donoso-Rengifo MC; Reyes-Torres I; Montejano Hervás P
Ther Drug Monit; 2017 Oct; 39(5):492-498. PubMed ID: 28682926
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate Elimination When Coadministered With Levetiracetam.
Reeves D; DiDominick S; Finn S; Kim HJ; Shake A
Ann Pharmacother; 2016 Dec; 50(12):1016-1022. PubMed ID: 27511814
[TBL] [Abstract][Full Text] [Related]
19. Using fluorescence polarization immunoassay for determination of erythrocyte methotrexate polyglutamates, a quick and easy test?
den Boer E; Koch BC; Huisman R; de Jonge R
Ther Drug Monit; 2014 Dec; 36(6):819-23. PubMed ID: 24739667
[TBL] [Abstract][Full Text] [Related]
20. Determination of methotrexate in serum: the aca MTHO immunoassay and HPLC compared.
Martz W; Oellerich M; Schumann G
J Clin Chem Clin Biochem; 1990 Dec; 28(12):951-3. PubMed ID: 2081968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]